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Sjögren's syndromeObjectives. Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease characterized by lymphocyte
inﬁltration into the salivary and lachrymal glands, leading to dry mouth and eyes. The presence of functional
autoantibodies against muscarinic type 3 receptor (M3R) has been reported in pSS patients. However, the
pathological role of anti-M3R autoantibodies in pSS salivary dysfunction remains controversial. Methods.
Puriﬁed IgGs were obtained from normal (control) and primary SS patients' sera (pSS IgG). Internalization of
M3R and clathrin was analyzed by biochemical assay and immunoﬂuorescence confocal microscopy using
human submandibular gland (hSMG) cells. Cytoplasmic free Ca2+ concentration ([Ca2+]i) was measured by
microspectroﬂuorimetry. Results. Incubation of hSMG cells with pSS IgG (1 mg/ml) signiﬁcantly decreased
M3R expression levels at the membrane. Carbachol-induced [Ca2+]i transients (CICTs) in these cells were also
inhibited by pSS IgG. In contrast to pSS IgG, control IgG had no effect on both the M3R expression level and
CICTs. We found that binding of pSS IgG to M3R induces phosphorylation of the receptor, and that the pSS
IgG-induced M3R internalization is prevented by the lysosomal inhibitor, chloroquine. In addition, pSS IgG
decreased membrane clathrin expression, which was inhibited by atropine. Our immunoﬂuorescence study
further conﬁrmed that pSS IgG induces a co-localization of M3R with clathrin and subsequent internalization
of M3R. Conclusion. pSS IgG induces internalization of M3R partly through a clathrin-mediated pathway. The
results suggest M3R internalization as a potential mechanism to explain the exocrinopathy seen in pSS patients.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Natural antibodies or autoantibodies in healthy individuals may
defend against infections and contribute to the homeostasis of the
immune system. In contrast, high-afﬁnity, mutated autoantibodies
reﬂect a pathologic process which disturbs antigen-receptor signaling
or cell functions [1]. Primary Sjögren's syndrome (pSS) is a systemic
autoimmune disease characterized by lymphocyte inﬁltration into
the salivary and lachrymal glands, leading to dry mouth and eyes [2].
Aside from sicca symptoms, there are often systemic ‘extraglandular’
manifestations involving gastrointestinal and urinary tract dysfunctions
[3]. SS patients' sera contain autoantibodies (SS IgG) directed againstntration; CCh, carbachol; CDE,
+]i transient; CQ, chloroquine;
dibular gland;M3R,muscarinic
f primary Sjögren's syndrome
gy, School of Dentistry, Seoul
ongeondong 28, Chongnoku,
658; fax: +82 2 762 5107.
rights reserved.organ- or tissue-speciﬁc autoantigens including the ribonucleoproteins
Ro (SS-A/Ro) and La (SS-B/La) [4], and carbonic anhydrase [5]. Autoan-
tibodies directed against muscarinic acetylcholine type 3 receptors
(M3R) have also been shown to exist in SS patients' sera [6–9] and in
an animal model of secretary dysfunction [10]. Anti-M3R autoanti-
bodies in particular have been shown to functionally inhibit salivary
secretion [11,12].
It is well known that water and electrolyte transport in salivary
glands are regulated by acetylcholine (ACh) released from parasympa-
thetic nerves.M3R, a prototypical G-protein-coupled receptor (GPCR) is
endogenously expressed in salivary glands and plays a critical role in
parasympathetic control of salivation in rodents and humans [13–16].
M3R couples to Gq/11 and produces inositol 1,4,5-trisphosphate (IP3),
which increases the intracellular free-Ca2+ concentration ([Ca2+]i)
and ultimately activates Ca2+-dependent K+ and Cl− channels
[17,18], resulting in the formation of primary saliva.
Our previous study showed that incubation of human submandib-
ular gland (HSG) cells with autoantibodies obtained from the sera of
SS patients inhibits M3R function in proportion to the length of the
incubation period [11]. The result suggests that besides a direct occu-
pation and blocking of the agonist binding site of M3R by SS IgG, other
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One possibility is the internalization of M3R. Agonist-dependent
regulation of GPCRs involves phosphorylation and subsequent
internalization [19]. Once internalized receptors are sorted and either
recycled back to the plasma membrane or degraded in lysosomes.
M3R is itself regulated by phosphorylation at serine and threonine
residues [20,21].
In the present study, we examined whether SS autoantibodies
induce internalization of M3R. We demonstrate for the ﬁrst time
that autoantibodies isolated from the sera of primary SS patients
(pSS IgG) induce dramatic down-regulation of M3R via internalization
and degradation of the receptors in primary human submandibular
gland (hSMG) cells, a mechanism which may contribute to salivary
hypofunction in SS patients.
2. Materials and methods
2.1. Reagents
Carbachol, atropine, chloroquine, poly-L-ornithine and Coomassi
Brilliant Blue were obtained from Sigma (Poole, UK). Normal donkey
serum and normal mouse IgG were purchased from Santa Cruz (CA,
USA). Anti-phosphoserine monoclonal antibodies were purchased
from Abnova (Taipei, Taiwan).
2.2. Patients and preparation of IgG
Serum samples were obtained from seven primary SS patients en-
rolled at the Rheumatology Clinic, Seoul National University Hospital
between September 2008 and March 2010. Patients were diagnosed
according to the revised international classiﬁcation criteria for prima-
ry Sjögren's syndrome [22]. All were females with ages ranging from
38 to 65 years (mean age 52.1±9.5 years) and gave their written in-
formed consent. All patients' sera were anti-Ro and ANA positive, and
approximately half were anti-La and RF positive (Table 1). Control
sera were obtained from ﬁve healthy controls' that did not show
any sign of SS symptoms and were negative in serologic tests. IgG
was prepared from control and SS patient sera using the caprylic
acid precipitation technique [23]. Puriﬁed control and SS IgG were
concentrated using a Minicon B15 concentrator (Millipore, MA,
USA) to 107.33±12.11 mg/ml (n=5 healthy controls) and 120.1±
10.52 mg/ml (n=7 pSS patients), respectively. Prepared IgG from in-
dividual patients was diluted individually to a ﬁnal concentration of
1 mg/ml for use in experiments. Data from multiple patients' IgGs
were pooled for analysis. The present study was approved by the
Medical Ethics Committee of Seoul National University.
2.3. Gradient native gel eletrophoresis and Coomassie staining
To conﬁrm puriﬁcation of IgG, a 100 μg sample of each puriﬁed IgG
was subjected to 4–12% gradient native PAGE (polyacrylamide gel
electrophoresis under non-denaturing conditions) and detected byTable 1
Clinical and serological tests of pSS cases.
Patient Dry mouth Dry eye Schirmer anti-Ro anti-La RF ANA
pSS#1 + + + + + − +
pSS#2 + + + + − − +
pSS#3 + + + + − ND +
pSS#4 + − + + + − +
pSS#5 + + ND + + + +
pSS#6 + + +/− + − + +
pSS#7 + + + + − + +
pSS: primary Sjögren's syndrome; ND: not detected.
+/−: a difference in Schirmer test result was observed between the two eyes.Coomassie Blue staining. A high range NativeMarkTM molecular
marker (Invitrogen, CA, USA) was used as a standard reference.
2.4. Source of human submandibular gland tissue
Human submandibular gland tissue was obtained from patients
who had submandibular glands resected as a treatment for a range
of oral tumors. The group included both men and women, with ages
ranging from 38 to 74 years. All patients gave informed consent for
participation in this study. After surgical excision, the glands were im-
mediately placed in cold (4 °C) physiological saline and transported
to the laboratory for the experiments. All tissue used for experiments
was retrospectively conﬁrmed as being histologically normal (results
not shown). The present study was approved by the Institutional Re-
view Board of Seoul National University Dental Hospital (CRI06002).
2.5. Preparation of primary human submandibular gland (hSMG) cells
Primary hSMG cells were prepared as described [18]. The tissue was
trimmed of connective tissue, fat and visible duct, and minced ﬁnely
with scissors in ice-cold Ca2+-free incubation solution that contained
(in mM): 130 NaCl; 4.5 KCl; 1 NaH2PO4·2H2O; 1 MgCl2; 10 D-glucose;
10 HEPES-Na, at pH 7.4. The minced tissue was then incubated for
20 min at 37 °C with Ca2+-free incubation solution containing
0.4 mg/ml trypsin (type XI; Sigma), followed by a second incubation
for 60 min in Ca2+-free incubation solution that contained 2 mg/ml
of trypsin inhibitor (Sigma), 0.04 mg/ml of collagenase (Worthington,
Lakewood, UK) and 1% BSA. The tissuewas thenmechanically dissociated
by repeated triturations through a 1 ml pipette tip at 20 min intervals
throughout the incubation period. The dissociated cells were harvested
at the end of incubation by ﬁltering the suspension through a nylon
mesh (200 μm), followed by centrifugation.
2.6. Membrane preparation and western blotting
Dissociated hSMG cells were incubated with normal bath solution
containing control or pSS IgG for indicated time periods at 37 °C with
shaking. Then the cells were washed and sonicated in ice-cold 20 mM
HEPES solution containing 1 mM MgCl2, 100 mM NaCl, 1 mM dithio-
threitol, 0.3 mM phenylmethylsulfonyl ﬂuoride (3×30 s, Branson
Sonifer) with pH 7.4. The samples were centrifuged at 600 ×g at
4 °C, and the supernatants were further centrifuged at 20,000×g at
4 °C. Both the pellets (P2 membrane fractions) and the corresponding
supernatants (crude cytosolic fractions) were subjected to SDS/PAGE
(50 μg of membrane protein and 300 μg cytosolic protein in each
lane) and immunoblotting [24]. Protein concentration was measured
by the BCA protein assay kit (Pierce, IL, USA) with bovine serum albu-
min as a standard. The protein samples were transferred to polyviny-
lidene diﬂuoride membranes (0.45 μm, Millipore) and probed with
monoclonal antibody speciﬁc for clathrin (Abcam, Cambridge, UK)
at a dilution of 1:4000, polyclonal antibody speciﬁc for muscarinic
type 3 receptor (M3R) (Abcam) at a dilution of 1:2000, polyclonal
antibody speciﬁc for β1 adrenergic receptor (Abcam) at a dilution
of 1:1000 and polyclonal antibody speciﬁc for Gβ (Santa Cruz) at a
dilution of 1:500. HRP-conjugated anti-mouse, rabbit or goat IgGs
were used as secondary antibodies (Santa Cruz), respectively, followed
by ECL detection of the corresponding protein bands.
2.7. Measurement of cytosolic free calcium concentration ([Ca2+]i)
Cells were loaded with 2 μM fura-2/AM (Molecular probes, Eugene,
OR, USA) for 45 min at room temperature. After washout of fura-2, the
cells were re-suspended in bath solution containing BSA (1%) and
stored on ice until use. The bath solution contained (in mM): 140
NaCl; 5 KCl; 1 MgCl2; 1 CaCl2; 10 D-glucose; 5 HEPES-NaOH, at pH 7.4.
For the recording, cells were placed on a glass coverslip at the bottom
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Fig. 1. Puriﬁcation of IgGs and pSS IgG-induced internalization of M3R (A) Puriﬁed IgGs
loaded on 4–12% native gel were shown as strong single bands by Coomassi blue staining
between 146 kDa and 242 kDa, corresponding to IgG mass (150 kDa) in all samples we
tested. IgGs were prepared from the sera of seven primary SS patients (pSS IgG, #1–7)
and ﬁve normal healthy controls (control IgG, #8–12). (B) hSMG cells were incubated
for indicated time with control or pSS IgG, as described. A representative immunoblotting
experiment is shown with anti-M3R, anti-β1 AR and anti-Gβ antibodies. Signals were
quantiﬁed by densitometry and normalized to the loading control, Gβ. (C) A summarized
result. The percentage ofmembraneM3Rwas calculated for each time point andplotted as
percentage of the control signal at 0 min. Incubation of the cells with pSS IgG (1 mg/ml)
signiﬁcantly decreased expression of M3R at the membrane with an concurrent increase
in protein in the cytosol (n=7, *Pb0.05).
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and superfused with bath solution heated to 37 °C at a ﬂow rate of
2–2.5 ml/min. Approximately 7–15 cells were recorded and analyzed
in each experiment, and the mean values from different cells and pa-
tients were averaged. Fura-2 ﬂuorescence was recorded at excitation
wavelengths of 340 and 380 nm, with an emission wavelength of
510 nm. MetaFluor®version 6.1 imaging system (Universal Imaging,
West Chester, PA) was used for the recording and analysis. The results
are presented as the 340 nm/380 nm ratio (Ca2+ ﬂuorescence ratio,
F340/F380). Stimulation with carbachol and/or treatment with normal
or SS IgG was achieved by the addition of the compounds to the bath
solution.
2.8. Immunoﬂuorescence confocal microscopy
For visualization of M3R, the treated cells were washed with PBS,
seeded on a coverslip coated with poly-L-ornithine and ﬁxed for 30 min
at room temperature with 3.7% paraformaldehyde in PBS, and then
simultaneously blocked and permeabilized in PBS containing 0.25% ﬁsh
gelatin, 0.04% saponin and 0.05% NaN3. After permeabilization, M3Rs
were labeled by incubation of cells with anti-M3R goat poly-clonal
antibody (Santa Cruz) at a dilution of 1:100 followed by incubation
with Alexa Fluor® 488 donkey anti-goat IgG (Invitrogen) at a dilution
of 1:200. For co-localization studies, cells were washed four times
with PBS and incubated with anti-clathrin mouse monoclonal antibody
(Abcam) at a dilution of 1:200, followed by PBS wash and incubation
with Alexa Fluor® 594 donkey anti-mouse IgG (invitrogen) at a dilution
of 1:200. Slides were mounted and visualized using a laser scanning
confocal microscopy (Fluoview300, Olympus, Japan).
2.9. Immunoprecipitation assay
Co-immunoprecipitation of phosphoserine or clathrin with M3R
was tested in a radioimmune precipitation assay of buffer-stripped
hSMG crude cytosolic fractions adjusted to 1% sodium deoxycholate
and 1% Triton X-100. Samples (0.2 mg/ml membrane fraction or
0.7 mg/ml cytosolic protein) were precleared with normal mouse
IgG and protein A/G PLUS-agarose (Santa Cruz) according to the man-
ufacturer's instruction. Isolated supernatants were incubated for 4 h
with mouse anti-clathrin monoclonal antibodies (Abcam) at a dilu-
tion of 1:500 at 4 °C with constant inverting. Immune complexes
were precipitated with protein A/G PLUS-agarose according to the
manufacturer's instruction and each immunoprecipitate was washed
5 times with radioimmune precipitation assay buffer. The pellets
were resuspended in 1× sample buffer and subjected to SDS/PAGE
followed by immunoblotting and ECL detection of the protein
bands. Polyclonal anti-M3R antibodies (Abcam) (dilution 1:2000)
were used to detect proteins.
2.10. Statistical analysis
All results are presented as a mean±SEM. n=number of experi-
mental repeats with individual patient IgG. Statistical analysis was
performed using One-way (*) or Two-way (#) repeated measures
ANOVA. Pb0.05 was considered statistically signiﬁcant.
3. Results
3.1. Internalization of muscarinic type 3 receptor (M3R) by pSS IgG
IgGs were prepared from the sera of seven primary SS patients
(pSS IgG, #1–7) and ﬁve normal healthy controls (control IgG, #8–12)
using the caprylic acid method. The purity of the IgG was conﬁrmed
by Coomassi blue staining after gradient native gel electrophoresis.
Under non-denaturing conditions, strong single bands were observed
between 146 kDa and 242 kDa, which correspond to IgG mass(150 kDa) in all samples we tested (Fig. 1A). To investigate whether
pSS IgG induces internalization of M3R, we performed western blot of
membrane protein proved with anti-M3R antibodies to detect expres-
sion level of M3R from the primary cultured hSMG cells. We compared
the M3R expression level before and after incubation of the cells with
control or pSS IgG for 30, 60 and 90 min.We used IgG at a concentration
of 1 mg/ml throughout the experiments. A representative experiment is
shown in Fig. 1B. Incubation of the cells with control IgG had little effect
on theM3R expression level at both themembrane and the cytosol. The
amount ofM3Rproteinwas110.2±8.6%, 102.0±6.7% and 119.0±9.2%
after incubation with control IgG for 30, 60 and 90 min, respectively
(n=4, P>0.1). However, incubation of the cells with pSS IgG for 30,
60 and 90 min gradually decreased expression ofM3R at themembrane
to 83.6±8.2%, 68.2±8.8% and 53.0±8.3%, respectively (n=7,
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Fig. 2. Inhibition of pSS IgG-induced internalization of M3R by chloroquine (CQ) and
pSS IgG-induced M3R phosphorylation (A) A representative western blot analysis
showing the expression level of membrane M3R protein after co-incubation of pSS
IgG with CQ (right panel). The amount of membraneM3Rwas modestly but reproducibly
recovered by CQ (100 μM). The lower histogram shows a summarized result. Signalswere
quantiﬁed by densitometry and membrane M3R was normalized to the loading control
(Gβ). CQ inhibited the pSS IgG-induced decrease in M3R protein at the membrane
(n=4, #Pb0.05, Two-way RM ANOVA). (B) pSS IgG-induced M3R phosphorylation.
Membrane M3R was dramatically decreased in proportion to the incubation periods,
while phosphorylated M3R was conversely increased in the pSS IgG group. Carbachol
(100 μM; CCh,) the positive control, also signiﬁcantly increased phosphorylation of M3R
(lane 6 in Fig. 2B). Gβwas used as a quantitative control for amount ofmembrane protein
loaded. Ig heavy chains (Ig HC) are derived from the Abs used in immunoprecipitation and
are recognized by the secondary Ab applied in immunoblotting. Data are representative of
three independent experiments.
164 M. Jin et al. / Biochimica et Biophysica Acta 1822 (2012) 161–167*Pb0.05). Conversely, cytosolicM3R proteinwas signiﬁcantly increased
(*Pb0.05). Each experimental repeat was carried out with IgG from in-
dividual patients; thus, pSS IgGs from all seven patients induced inter-
nalization of M3R. To conﬁrm whether the internalization of M3R by
pSS IgG was a receptor-speciﬁc phenomenon, we detected another
GPCR, the β1 adrenergic receptor (β1 AR), which plays a main role in
salivary protein secretion through G-protein/adenylate cyclase and
cAMP signaling [13]. However, unlikeM3R the level ofβ1AR expression
either at the membrane or in the cytosol was not affected by pSS IgG
preincubation (Fig. 1B). We also examined whether Gβ, a subunit of
G-protein in GPCR signaling, was involved in the pSS IgG-induced
M3R internalization. The majority of Gβ protein was detected in the
membrane fraction of the hSMG cells, though a small amount of Gβ
was also observed in the cytosolic fraction (Fig. 1B). Neither membrane
nor cytosolic Gβ proteinwas altered by the incubation of the hSMG cells
with pSS IgG. Therefore, Gβ was used as a quantitative control for all
subsequent experiments. These results suggest that pSS IgG-induced
M3R internalization is speciﬁc to autoantibodies against M3R. Fig. 1C
shows a summarized result.
3.2. Inhibition of pSS IgG-induced M3R internalization by chloroquine
and increase in M3R phosphorylation by pSS IgG incubation
Although incubation of hSMG cells with pSS IgG gradually de-
creased expression of M3R at the membrane with a concurrent in-
crease in the cytosol, the levels of cytosolic M3R detected after
incubation of pSS IgG for 90 min were less compared with the
60 min time point, indicating that some degradation of M3R may
have occurred (see Fig. 1B). Thus, we examined the effect of the lyso-
somal inhibitor chloroquine (CQ) [25] on pSS IgG-induced internali-
zation of M3R. A representative experiment is shown at the top of
Fig. 2A. The internalization of M3R induced by pSS IgG was reproduc-
ibly inhibited by CQ (100 μM). Lower histogram of Fig. 2A shows a
summarized result. The amount of membrane M3R protein was 97.
7±10.7%, 92.0±14.0% and 89.8±18.3% after incubation with pSS
IgG for 30, 60 and 90 min, respectively (n=4, #Pb0.05 compared to
the pSS IgG treated group). Agonist-induced internalization of M3R
is known to be facilitated by phosphorylation of the receptor [26].
Therefore, we next examined whether pSS IgG induce phosphoryla-
tion of M3R using a co-immunoprecipitation assay (Fig. 2B). pSS IgG
(lanes 4–5) dramatically increased the amount of phosphorylated
M3R compared to control IgG (lanes 1–2). As expected, the positive
control, M3R agonist carbachol (100 μM; CCh,), also signiﬁcantly in-
creased phosphorylation of M3R (lane 6 in Fig. 2B). Gβ was used as
a quantitative marker for the total amount of membrane protein load-
ed. Equal primary antibody loading for immunoprecipitation was
conﬁrmed by detection of Ig heavy chains (Ig HC) recognized by the
secondary antibodies applied in immunoblotting. Data are represen-
tative of three independent experiments.
3.3. Inhibition of carbachol-induced [Ca2+]i transient (CICT) by pSS IgG
To test the effect of pSS IgG onM3R function, we next examined the
effect of pSS IgG on the carbachol-induced [Ca2+]i transient (CICT) in
hSMG cells (Fig. 3A). Stimulation of the cells with 10 μM carbachol
(CCh) consistently evoked a transient [Ca2+]i increase (the upper
panel in Fig. 3A). Preincubation of the cells with 1 mg/ml control IgG
for 30, 60 and 90 min had no effect on the magnitude of the CICT (the
middle panel in Fig. 3A) compared to the non-treated group (the
upper panel in Fig. 3A). However, the magnitude of the CICT was
dramatically reduced by preincubation with 1 mg/ml pSS IgG (the
lower panel in Fig. 3A). The magnitudes of CICT were signiﬁcantly
reduced to 65.5±7.2%, 53.5±8.7% and 37.9±8.1% after pSS IgG
preincubation for 30, 60 and 90 min, respectively (n=6, *Pb0.05);
thus the inhibitory effect of pSS IgG on the CICT was in proportion to
the incubation period. Fig. 3B shows a summarized result. Interestingly,a discrepancy between the relative inhibition of CICT and the reduction
of M3R membrane expression remained at a constant value of approx-
imately 15% throughout the experiment (Fig. 3C).3.4. Role of clathrin in pSS IgG-induced M3R internalization
Clathrin-dependent endocytosis (CDE) is one of the main path-
ways for M3R internalization [24]. Thus, we examined whether pSS
IgG-induced M3R internalization is mediated by CDE. We measured
the amount of clathrin protein at the membrane and cytosolic fraction
via western blot analysis with anti-clathrin antibodies. A representa-
tive experiment is shown in Fig. 4A. Incubation of the cells with pSS
IgG for 60 and 90 min signiﬁcantly decreased clathrin at the mem-
brane to 75.1±9.5% and 65.1±3.6%, respectively (n=7, *Pb0.05).
The simultaneous application of atropine (10 μM), a non-speciﬁc
muscarinic receptor antagonist, or the lysosomal inhibitor chloro-
quine (100 μM; CQ) with pSS IgG prevented the loss of clathrin at
the membrane region compared to pSS IgG alone (n=3 and n=4, re-
spectively; #Pb0.05, Two-way RM ANOVA). Incubation of hSMG cells
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brane. Fig. 4B shows a summarized result.
3.5. pSS IgG -induced interaction and colocalization of M3R with clathrin
We performed a co-immunoprecipitation assay using anti-clathrin
antibodies to conﬁrm direct interaction of M3R with clathrin in the
cytosol. Immunoprecipitation of M3R with clathrin from the cytosolic
fraction was observed after incubation with pSS IgG, but not control
IgG (Fig. 5A). Data are representative of three independent experi-
ments. We ﬁnally investigated co-localization of M3R with clathrin
after pSS IgG incubation using dual-labeled confocal microscopy.
Prior to pSS IgG incubation, M3R (green color) was located predomi-
nantly at the cell membrane surface, while clathrin (red color) was
found in the cytosol, indicating that M3R does not colocalize with cla-
thrin in the resting state (Fig. 5B). Incubation of hSMG cells with con-
trol IgG for 30 min had no effect on the subcellular localization of M3Rand clathrin (Fig. 5C). In contrast, 30 min after incubation with pSS
IgG, M3R colocalized with clathrin (merged yellow color) at the
membrane region (Fig. 5E). An increase in merged yellow vesicles
was then seen in the cytosol after 60 min pSS IgG incubation, result-
ing in the dramatic reduction of M3R at the membrane surface
(Fig. 5F) suggesting that pSS IgG induced an internalization of M3R.
We tested the effect of CCh on M3R internalization as a positive con-
trol [24,26]. Treatment of the cells with CCh (100 μM) induced a rapid
internalization of M3R, which co-localized with clathrin in the cytosol
30 min after incubation with pSS IgG (Fig. 5D).
4. Discussion
Autoantibodies serve as biomarkers in certain autoimmune disor-
ders. Their remarkable speciﬁcity and presence before disease onset
provides an opportunity for early diagnosis and therapeutic interven-
tion. According to the European–American Diagnostic Criteria, Sjögren's
syndrome (SS) diagnosis includes the presence of autoantibodies
against ribonucleoprotein Ro and La [22]. Rheumatoid factor (RF) and
antinuclear antibodies (ANA) may also found be in patients with SS
[27]. Recent evidence supports the existence of anti-M3R autoanti-
bodies in the sera of primary Sjögren's syndrome (pSS) patients, as de-
termined by serologic tests [6,7] and functional studies [12,28]. The
second and/or third extracellular loops of M3R were identiﬁed as the
functional epitopes which may interact with SS IgG [29]. Therefore, oc-
cupation of the agonist binding site bypSS IgGhas been proposed as one
of themajor mechanisms to explain the functional inhibition of M3R by
speciﬁc autoantibodies [11,30]. However, the increasing inhibitory ef-
fect of SS IgG on M3R function by prolonged incubation, as observed
in our previous study [11], suggests that an additional inhibitory mech-
anismmay be involved. Here, we demonstrate for the ﬁrst time that pSS
IgG induce internalization of M3R in a receptor-speciﬁc manner.
Among the various subtypes of muscarinic receptors, M3R plays an
important role in secretary processes in human salivary glands
[15,16]. In the present study, we observe the novel ﬁnding that M3R,
pSS IgGControl IgG
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0
Fig. 5. pSS IgG-induced interaction and co-localization of M3R with clathrin. (A) Co-immunoprecipitation of M3Rwith clathrin in the cytosol was observed in the pSS IgG but not control
IgG group. Ig heavy chains (Ig HC) are derived from the Abs used in immunoprecipitation and are recognized by the secondary Ab applied in immunoblotting. Data are representative of
three independent experiments. Dual immunoﬂuorescence labeling ofM3R (green) and clathrin (red) in hSMGcells under the following conditions: (B) Non-treatment; (C) Incubation of
the cells with control IgG (1 mg/ml) for 30 min; (D) Incubation of the cells with CCh (100 μM) for 30 min; (E–G) Incubation of the cells with pSS IgG (1 mg/ml) for 30 min (E), 60 min (F),
90 min (G). Incubationwith pSS IgG, but not control IgG, induced co-localization ofM3Rwith clathrin (merged yellow color). CCh inducedmore rapid internalization ofM3R co-localized
with clathrin compared to pSS IgG. Data are representative of three independent experiments. Scale bars=10 μm.
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regulated by pSS IgG via receptor phosphorylation and internalization.
It is known that receptor phosphorylation can modulate receptor inter-
nalization in several G-protein-coupled receptors (GPCRs) including
M3R [26,31]. Internalization of M3R by agonist stimulation is facilitated
by phosphorylation of the receptor at serine/threonine residues in the
third cytoplasmic loop and C-terminus of the receptor [20,21]. Thus,
phosphorylation of M3R might be an important intermediate process
linking direct binding of the receptor by pSS IgG with the triggering of
endocytosis. In our experiment, pSS IgG induced phosphorylation and
internalization of M3R but it did not evoke any increase of intracellular
calcium (data not shown), unlike the M3R agonist CCh, which induced
both a [Ca2+]i transient and internalization of M3R. It is known that
other GPCRs can be internalized without activating the Gq signaling
pathway; examples being angiotensin II type 1 receptor signalingmedi-
ated by modiﬁed biased ligand angiotensin II [32] and endogenous
CXCR7 signaling [33]. Consistent with this hypothesis, clathrin but not
Gβ was decreased at the plasma membrane by pSS IgG. Therefore, pSS
IgG appears to induce clathrin coat-dependent internalization of M3R
without activating Gq signaling.
We further conﬁrmed the interaction of M3R with clathrin after pSS
IgG incubation by co-immunoprecipitation assay and immunoﬂuores-
cence confocal microscopy. These results demonstrate that pSS IgG in-
duce M3R internalization at least in part through a clathrin-mediated
endocytosis pathway. Internalization of GPCR by an endocytic pathway
is highly regulated and generally considered to be a ligand binding-
dependent process [34]. However, GPCRs can also be endocytosed in
the absence of agonist, in a process known as constitutive internalization
[35]; for example protease-activated receptor-1 [36] and transferrin re-
ceptor [37] internalize constitutively but in a clathrin- and dynamin-
dependent manner. In the present study, internalization of M3R was
not observed in the absence of agonist stimulation for 90 min (datanot shown). Scarselli et al. [38] demonstrated that there are two pat-
terns for M3R internalization: 1) slow constitutive internalization by
clathrin-independent endocytosis, and 2) rapid internalization after ag-
onist stimulation by clathrin-dependent endocytosis. In keeping with
the latter mechanism, CCh induced a rapid internalization of M3R that
was co-localized with clathrin and is consistent with a previous study
[26]. pSS IgG also induced clathrin-dependent M3R internalization but
at a more moderate rate. The reason for this difference in pSS IgG- and
CCh- induced M3R internalization is not clear but the different kinetics
of internalization by individual ligands may be a consequence of an al-
ternative sorting pathway.
In our study, M3R internalization correlated well to the increase in
M3R in the cytosol. Interestingly, 90 min after incubation with pSS
IgG, the amount of cytosolic M3R protein was decreased, suggesting
that internalized M3Rs were degraded. This process appears to be a
prerequisite for the continuing receptor internalization, as the lyso-
somal inhibitor, chloroquine, which is known to interrupt the trafﬁck-
ing of endosomes to lysosomes [25], prevented the pSS IgG-induced
internalization of M3R. This result suggests that block of endosomal
trafﬁcking results in the upstream interruption of pSS IgG-mediated
internalization and that endosome recycling may be a rate-limiting
step in this process.
In our study we observed a relative difference between the reduc-
tion in M3R function (CICT) and membrane M3R expression by pSS
IgG (see Fig. 3C). Based on our previous report [39], it appears that
acute receptor inhibition – caused by occupation of the agonist bind-
ing site by pSS IgG – may contribute up to 15% of the total inhibition
of M3R by pSS IgG. Our current data demonstrate that the remaining
chronic inhibitory component, which increases proportionately to the
incubation period, is due to M3R receptor internalization. We there-
fore suggest M3R internalization as one of the critical mechanisms re-
sponsible for the inhibition of M3R function by autoantibodies.
167M. Jin et al. / Biochimica et Biophysica Acta 1822 (2012) 161–167Antigenic modulation has also been reported in other autoimmune
diseases. For example, one of the major mechanisms of disease
pathology in myasthenia gravis is the binding, internalization, and
eventual destruction of acetylcholine receptors (AChR) by cross-linking
AChR-speciﬁc autoantibodies [40,41]. Such antigenic modulation
ultimately attenuates the ability of muscle cells to contract in response
to signals from neurons, leading to muscle weakness, although in this
disease AchR internalization occurs in the absence of clathrin [42].
In conclusion, we propose that pSS IgG inhibit M3R function in two
ways: First, M3R is acutely desensitized by direct occupation of agonist
binding sites of the receptor by pSS IgG and phosphorylation of the
receptor. Subsequently we have shown that in the continued presence
of pSS IgG, M3R function is further decreased by clathrin-dependent
receptor internalization. After internalization of M3R, abundant pSS
IgGs may bind to unoccupied M3Rs thus resulting in a progressive
and long-term loss of M3R function. Our novel ﬁnding may provide
some important clues in understanding the exocrinopathy observed
in Sjögren's syndrome patients in relation to salivary dysfunction
and may point to new therapeutic approaches to this disease.
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